We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Biden administration has pledged to pour almost $3 billion into beefing up domestic COVID-19 vaccine manufacturing as it considers a potential mass program of booster shots. Read More
The Biden administration’s plan for a Sept. 20 rollout of vaccine booster shots may be delayed as the FDA and the Centers for Disease Control and Prevention (CDC) consider the available data for the Pfizer/BioNTech, Moderna and Johnson & Johnson (J&J) boosters. Read More
The FDA is deliberating between approving a booster shot of Moderna’s COVID-19 vaccine at a 50 microgram (mcg) level or at a current 100 mcg level, the latter being the level that make up the first two doses each of the vaccine. Read More
The FDA announced that it will hold an advisory committee meeting Sept. 17 to discuss the third booster for the Pfizer/BioNTech mRNA COVID-19 vaccine for people age 16 years and older. Read More
A county judge in Ohio has issued a court order forcing a Cincinnati hospital to give the anti-parasitic ivermectin for three weeks to a man suffering with COVID-19. Read More
The FDA has reissued its emergency use authorization (EUA) for Eli Lilly’s monoclonal antibodies bamlanivimab and etesevimab for treatment of COVID-19 — but only for certain states. Read More
Overdoses of ivermectin are linked with low blood pressure, decreased consciousness, confusion, hallucinations, seizures, coma and even death. Read More
In a separate contamination incident, Japan last week halted the use of 1.63 million Moderna doses distributed to vaccination centers due to possible contamination. Read More
Moderna said it has completed submitting data for its COVID-19 vaccine’s rolling biologics license application (BLA) and has requested an FDA Priority Review, which would require the FDA to make its decision within 60 days. Read More
Johnson & Johnson (J&J) has announced that it will submit data to the FDA showing that its booster shot dramatically raises the levels of antibodies against COVID-19 in people vaccinated six months prior. Read More
The FDA has granted full approval to Pfizer’s/BioNTech’s mRNA COVID-19 vaccine in people age 16 years and older. The move is expected to ease worries among some as-yet-unvaccinated people, as well as inspiring more vaccine mandates from businesses and institutions. Read More